Literature DB >> 21452071

The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Qi-Rong Xu1, Xue-Peng Zhuge, He-Lin Zhang, Yu-Min Ping, Long-Qi Chen.   

Abstract

BACKGROUND: The recently published AJCC-TNM staging system for esophageal carcinoma made an obvious modification on N-classification based on the number of metastatic regional lymph nodes (LN). However, this classification might ignore the site at which these LNs occur, a factor that might be even more important in reflecting patients' prognosis.
METHODS: A retrospective study of 236 patients with carcinoma of thoracic esophagus who underwent esophagectomy between 1984 and 1989 with each at least six LNs removed was conducted, with a 10-year follow-up rate of 92.4%. The proposed scheme for N-classification according to the number (0, 1-2, 3-6, ≥7; N0-3), distance (0, 1, 2, 3 stations; S0-3), or extent (0, 1, and 2 fields; F0-2) of LN involvement was evaluated by univariate and multivariate survival analysis.
RESULTS: The LN metastasis was identified in 112 patients, revealing a poorer 5-year survival in this patient group when compared to patients without node involvement. Cox regression analysis revealed that the number and distance of LN metastases and the number of metastasis fields were factors significantly influencing survival. When these factors were further analyzed by univariate log-rank test, no significant difference in survival existed between N2 and N3 patients, or among S1, S2, and S3 patients. When patients were grouped according to the extent of LN metastasis, significant differences in survival were observed overall and between each subgroup.
CONCLUSIONS: Refining the current N-classification for esophageal cancer according to the extent of LN metastasis, rather than by number alone, might be a better means of staging that could subgroup patients more effectively and result in different rates of survival.

Entities:  

Mesh:

Year:  2011        PMID: 21452071     DOI: 10.1007/s00268-011-1015-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

Review 1.  Esophageal carcinoma: current controversies.

Authors:  T R DeMeester
Journal:  Semin Surg Oncol       Date:  1997 Jul-Aug

2.  The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

Authors:  Nabil Rizk; Ennapadam Venkatraman; Bernard Park; Raja Flores; Manjit S Bains; Valerie Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

3.  Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.

Authors:  Dipok Kumar Dhar; Shinji Hattori; Yasuhito Tonomoto; Tadakazu Shimoda; Hoichi Kato; Mitsuo Tachibana; Kosho Matsuura; Yojiro Mitsumoto; Alex G Little; Naofumi Nagasue
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

4.  Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Muneaki Shibakita; Yasuhito Tonomoto; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Am J Surg       Date:  2005-01       Impact factor: 2.565

5.  [The number of lymph node with metastases influences survival in patients with cancer of the thoracic esophagus].

Authors:  Y Xu; Z Guo
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2000-05

6.  Clinicopathologic characteristics and postoperative outcome in Japanese and Chinese patients with thoracic esophageal cancer.

Authors:  W Adachi; S Koike; Y Nimura; N Koide; F Iida; X Q Du; Y M Ping; M He; L Q Chen; M D Zhang; H L Zhang
Journal:  World J Surg       Date:  1996 Mar-Apr       Impact factor: 3.352

7.  Prognostic significance of lymph node metastases and ratio in esophageal cancer.

Authors:  Matthew Wilson; Ernest L Rosato; Karen A Chojnacki; Inna Chervoneva; John C Kairys; Herbert E Cohn; Francis E Rosato; Adam C Berger
Journal:  J Surg Res       Date:  2007-08-28       Impact factor: 2.192

8.  The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.

Authors:  H-L Zhang; L-Q Chen; R-L Liu; Y-T Shi; M He; X-L Meng; S-X Bai; Y-M Ping
Journal:  Dis Esophagus       Date:  2009-04-15       Impact factor: 3.429

9.  Proposed modification of nodal status in AJCC esophageal cancer staging system.

Authors:  Wayne Hofstetter; Arlene M Correa; Neby Bekele; Jaffer A Ajani; Alexandria Phan; Ritsuko R Komaki; Zhongxing Liao; Dipen Maru; Tsung T Wu; Reza J Mehran; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Ashleigh Francis; Shanda Blackmon; Stephen G Swisher
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

10.  Total number of resected lymph nodes predicts survival in esophageal cancer.

Authors:  Nasser K Altorki; Xi Kathy Zhou; Brendon Stiles; Jeffrey L Port; Subroto Paul; Paul C Lee; Madhu Mazumdar
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

View more
  18 in total

1.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

2.  Estimating the need for neck lymphadenectomy in submucosal esophageal cancer using superparamagnetic iron oxide-enhanced magnetic resonance imaging: clinical validation study.

Authors:  Satoru Motoyama; Koichi Ishiyama; Kiyotomi Maruyama; Komei Narita; Yoshihiro Minamiya; Jun-Ichi Ogawa
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 3.  Strategies of nodal staging of the TNM system for esophageal cancer.

Authors:  Wen-Ping Wang; Song-Lin He; Yu-Shang Yang; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2018-02

4.  Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.

Authors:  Hang Li; Tian-wu Chen; Zhen-lin Li; Xiao-ming Zhang; Xiao-li Chen; Li-ying Wang; Li Zhou; Rui Li; Chun-ping Li; Xiao-hua Huang
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

Review 5.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27

6.  Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer.

Authors:  Qi-Xin Shang; Yu-Shang Yang; Wei-Peng Hu; Yong Yuan; Ai-Fang Ji; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2019-08

7.  The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.

Authors:  Xiao-Ling Xu; Wei-Hui Zheng; Shuang-Mei Zhu; An Zhao; Wei-Min Mao
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma.

Authors:  Xufeng Guo; Teng Mao; Zhitao Gu; Chunyu Ji; Wentao Fang
Journal:  Thorac Cancer       Date:  2015-03-02       Impact factor: 3.500

9.  Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population.

Authors:  Yaping Xu; Youhua Jiang; Xinmin Yu; Qixun Chen; Xinming Zhou; Weimin Mao
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

10.  Value of Nomogram Incorporated Preoperative Tumor Volume and the Number of Postoperative Pathologically Lymph Node Metastasis Regions on Predicting the Prognosis of Thoracic Esophageal Squamous Cell Carcinoma.

Authors:  Xinwei Guo; Han Zhang; Liben Xu; Shaobing Zhou; Juying Zhou; Yangchen Liu; Shengjun Ji
Journal:  Cancer Manag Res       Date:  2021-06-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.